<DOC>
	<DOCNO>NCT03061851</DOCNO>
	<brief_summary>The patient type 2 diabetes underwent routine hypoglycemic agent insulin therapy evaluate 48 week maltose software .</brief_summary>
	<brief_title>The Individualized Behavioral Intervention Smartphone App Treatment Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>This study enrol 400 patient type 2 diabetes five center Shandong Province , China . Patients type 2 diabetes meet inclusion / exclusion criterion randomly assign trial group ( conventional treatment + maltose app ) control group ( conventional treatment ) 1 : 1 ratio . The control group : give conventional hypoglycemic drug treatment , treatment plan investigator accord patient 's condition may , study interfere . The trial group : patient treat conventional hypoglycemic drug . The treatment plan decide researcher accord patient 's condition . The intervention do study . Interventions include : 1 . Weekly diabetes-related science article . 2 . Patients report hypoglycemia adverse reaction , competent physician deal . 3 . Questionnaires publish hospital ( 2 week 1 ) , feedback problem . 4. monitor abnormal blood glucose data presence relate discomfort , communicate competent physician online . 5 . Personalize development diet , exercise program . 6. different insulin oral hypoglycemic drug medication time remind . 7. hypoglycemic drug side effect query .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>1 . Male female patient diagnose type 2 diabetes , age ≥ 18 year ≤ 65 year ; 2. diagnosis type 2 diabetes ≥6 month ; 3 . The patient sign informed consent form agree collect data . The trial group agree apply maltose app trial period study popular science article , receive software reminder answer question regularly ; 4 . HbA1c≥7.0 % last one ( ≤3 month ) enrollment ; 5. able use Mobile App ; 6 . The mobile phone use patient must support maltose App installation . 7 . Receiving regular diabetes education hospital . 1 . Has participate randomize control clinical study ; 2 . To longterm use insulin pump main treatment type 2 diabetes ; 3. patient type 1 diabetes ; 4. pregnant lactate woman ; 5. doctor , alcohol , drug abuse , schizophrenia , severe vision hearing impair ; 6 . Can accept software manager ; 7 . Other investigator consider inappropriate participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>